Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 4 minute read Pharma Industry News Eosera appoints Shilpi Jain as Senior Director of Innovation to expand R&D-led ear care portfolio Eosera appoints R&D veteran Shilpi Jain as Senior Director of Innovation to lead next-gen ear care product development and accelerate growth in the OTC market. bySoujanya RaviAugust 5, 2025